Medrobotics Appoints Richard S. Walsh Vice-President Global Sales

Company Prepares for Commercialization of the Ground-Breaking Flex™ Robotic System in Otolaryngology

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Corp., an emerging medical robotics company developing the innovative Flex™ Robotic System, announced the appointment of Richard S. Walsh as Vice-President Global Sales today. The appointment coincides with Medrobotics’ anticipated commercial launches in Europe and the United States.

“He brings extensive experience in building highly-trained sales teams and driving early adoption of cutting-edge surgical systems, including robotics and ENT devices.”

“We are delighted to have Richard join our growing company,” said Samuel Straface, Ph.D., president and CEO of Medrobotics. “He brings extensive experience in building highly-trained sales teams and driving early adoption of cutting-edge surgical systems, including robotics and ENT devices.” Under Mr. Walsh’s sales leadership over the next several months the company will be preparing for commercialization of the Flex Robotic System, a platform to provide minimally invasive transoral access and visualization for surgery in hard-to-reach locations in the throat and voice box.

Prior to joining Medrobotics, Mr. Walsh was Vice President of Sales for NeoTract, Inc., a novel urology surgical device company. Mr. Walsh previously held executive sales positions at Acclarent, where he helped develop the US and international minimally invasive balloon sinuplasty marketplace and led the organization in revenue growth for four years. Prior to Acclarent, Mr. Walsh held executive positions at Atricure, Stereotaxis, and Intuitive Surgical during the early commercialization of the DaVinci surgical robot. “I am very excited to be part of the Medrobotics team,” said Mr. Walsh. “Over the course of my career, I have been fortunate to have worked for some of the world’s most innovative medical device companies, and I believe Medrobotics is one of them.”

The Flex Robotic System is anticipated to provide a cost‐effective, robot-assisted surgical platform for hospitals and surgeons eager to expand their offering of minimally-invasive treatment options. Minimally-invasive surgery has been shown to be more cost-effective and less painful for the patient and leads to quicker hospital discharge and faster recovery. “I look forward to introducing our leading-edge products to hospitals and surgical teams worldwide so they and their patients can benefit from the technology,” said Mr. Walsh.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex Robotic System, a robotic-assist platform that enables surgeons to gain single-site access and visualization to difficult-to-access anatomical locations. The robot provides a precise and stable platform for enhanced visualization and enables two-handed dexterity with compatible third-party instruments having tactile feedback.